Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 894-901

  Dupiereux, Ingrid ^a   Zorzi, Willy ^a   Lins, Laurence ^a   Brasseur, Robert ^a   Colson, Pierre ^a   Heinen, Ernst ^a   Elmoualij, Benaïssa ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

sheet; 106 126 Prion peptide; Circular dichroism; Lipid fusion; Liposomes

Indexed keywords

HYBRID PROTEIN; LACTATE DEHYDROGENASE; LIPID; LIPOSOME; PRION PROTEIN;

ARTICLE; BETA SHEET; CELL MEMBRANE; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ASSAY; HUMAN; HUMAN CELL; LIPID MEMBRANE; LIPID VESICLE; MOLECULAR MODEL; NEUROBLASTOMA; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE;

CELL LINE, TUMOR; CIRCULAR DICHROISM; HUMANS; LIPID METABOLISM; MEMBRANE FUSION; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PRIONS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 18844453149     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.012     Document Type: Article

References (41)

1. D.C. Gajdusek, C.J. Gibbs, and M. Alpers Experimental transmission of a Kuru-like syndrome to chimpanzees Nature 209 1966 794 796
2. J. Clinton, C. Forsyth, M.C. Royston, and G.W. Roberts Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study Neuroreport 4 1993 65 68
3. H. Fraser Diversity in the neuropathology of scrapie-like diseases in animals Br. Med. Bull. 49 1993 792 809
4. M. Jeffrey, C.M. Goodsir, M.E. Bruce, P.A. McBride, and C. Farquhar Morphogenesis of amyloid plaques in 87V murine scrapie Neuropathol. Appl. Neurobiol. 20 1994 535 542
5. S.B. Prusiner Prions Proc. Natl. Acad. Sci. USA 95 1998 13363 13383
6. T. Pillot, M. Goethals, B. Vanloo, C. Talussot, R. Brasseur, J. Vandekerckhove, M. Rosseneu, and L. Lins Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide J. Biol. Chem. 271 1996 28757 28765
7. J. McLaurin, and A. Chakrabartty Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity J. Biol. Chem. 271 1996 26482 26489
8. J. McLaurin, and A. Chakrabartty Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes Eur. J. Biochem. 245 1997 355 363
9. T. Pillot, L. Lins, M. Goethals, B. Vanloo, J. Baert, J. Vandekerckhove, M. Rosseneu, and R. Brasseur The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion J. Mol. Biol. 274 1997 381 393
10. M.P. Mingeot-Leclercq, L. Lins, M. Bensliman, B.F. Van, S.P. Van Der, J. Peuvot, A. Schanck, and R. Brasseur Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus Chem. Phys. Lipids 120 2002 57 74
11. R. Brasseur Tilted peptides: a motif for membrane destabilization (hypothesis) Mol. Membr. Biol. 17 2000 31 40
12. R. Brasseur Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations J. Biol. Chem. 266 1991 16120 16127
13. G. Forloni, N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, and F. Tagliavini Neurotoxicity of a prion protein fragment Nature 362 1993 543 546
14. D.R. Brown, B. Schmidt, and H.A. Kretzschmar Role of microglia and host prion protein in neurotoxicity of a prion protein fragment Nature 380 1996 345 347
15. F. Tagliavini, F. Prelli, L. Verga, G. Giaccone, R. Sarma, P. Gorevic, B. Ghetti, F. Passerini, E. Ghibaudi, and G. Forloni Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro Proc. Natl. Acad. Sci. USA 90 1993 9678 9682
16. G.L. De, C. Selvaggini, E. Ghibaudi, L. Diomede, O. Bugiani, G. Forloni, F. Tagliavini, and M. Salmona Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein J. Biol. Chem. 269 1994 7859 7862
17. M.F. Jobling, L.R. Stewart, A.R. White, C. McLean, A. Friedhuber, F. Maher, K. Beyreuther, C.L. Masters, C.J. Barrow, S.J. Collins, and R. Cappai The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126 J. Neurochem. 73 1999 1557 1565
18. 2+ interaction with Alzheimer amyloid beta protein calcium channels Proc. Natl. Acad. Sci. USA 93 1996 1710 1715
19. M. Kawahara, Y. Kuroda, N. Arispe, and E. Rojas Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line J. Biol. Chem. 275 2000 14077 14083
20. L. Diomede, S. Sozzani, W. Luini, M. Algeri, G.L. De, R. Chiesa, P.M. Lievens, O. Bugiani, G. Forloni, F. Tagliavini, and M. Salmona Activation [PrP-(106-126)] on human leucocytes Biochem. J. 320 Pt. 2 1996 563 570
21. M. Salmona, G. Forloni, L. Diomede, M. Algeri, G.L. De, N. Angeretti, G. Giaccone, F. Tagliavini, and O. Bugiani A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity Neurobiol. Dis. 4 1997 47 57
22. D.R. Brown, J. Herms, and H.A. Kretzschmar Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment Neuroreport 5 1994 2057 2060
23. J. Chabry, C. Ratsimanohatra, I. Sponne, P.P. Elena, J.P. Vincent, and T. Pillot In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression J. Neurosci. 23 2003 462 469
24. W.T. Norton, T. Abe, S.E. Poduslo, and G.H. DeVries The lipid composition of isolated brain cells and axons J. Neurosci. Res. 1 1975 57 75
25. G. Ansell, and J. Hawthorn Phospholipids, chemistry, metabolism and function 1964 Elsevier Amsterdam
26. M.P. Mingeot-Leclercq, X. Gallet, C. Flore, B.F. Van, J. Peuvot, and R. Brasseur Experimental and conformational analyses of interactions between butenafine and lipids Antimicrob. Agents Chemother. 45 2001 3347 3354
27. G.R. Bartlett Phosphorus assay in column chromatography J. Biol. Chem. 234 1959 466 468
28. B.F. Van, P.M. Tulkens, R. Brasseur, and M.P. Mingeot-Leclercq Aminoglycoside antibiotics induce aggregation but not fusion of negatively-charged liposomes Eur. J. Pharmacol. 289 1995 321 333
29. D. Hoekstra, B.T. de, K. Klappe, and J. Wilschut Fluorescence method for measuring the kinetics of fusion between biological membranes Biochemistry 23 1984 5675 5681
30. 2+-induced fusion and destabilization of liposomes Biochemistry 24 1985 3099 3106
31. L. Lins, R. Brasseur, P.M. De, J.P. Van Biervliet, J.M. Ruysschaert, M. Rosseneu, and B. Vanloo Helix-helix interactions in reconstituted high-density lipoproteins Biochim. Biophys. Acta 1258 1995 10 18
32. P. Ducarme, M. Rahman, and R. Brasseur IMPALA: a simple restraint field to simulate the biological membrane in molecular structure studies Proteins 30 1998 357 371
33. S. Thellung, V. Villa, A. Corsaro, S. Arena, E. Millo, G. Damonte, U. Benatti, F. Tagliavini, T. Florio, and G. Schettini p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells Neurobiol. Dis. 9 2002 69 81
34. N. Sanghera, and T.J. Pinheiro Binding of prion protein to lipid membranes and implications for prion conversion J. Mol. Biol. 315 2002 1241 1256
35. Y. Gu, H. Fujioka, R.S. Mishra, R. Li, and N. Singh Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP J. Biol. Chem. 277 2002 2275 2286
36. M.C. Lin, T. Mirzabekov, and B.L. Kagan Channel formation by a neurotoxic prion protein fragment J. Biol. Chem. 272 1997 44 47
37. T. Pillot, B. Drouet, M. Pincon-Raymond, J. Vandekerckhove, M. Rosseneu, and J. Chambaz A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons J. Neurochem. 75 2000 2298 2308
38. J.M. Mancheno, M. Gasset, J.P. Albar, J. Lacadena, P.A. Martinez del, M. Onaderra, and J.G. Gavilanes Membrane interaction of a beta-structure-forming synthetic peptide comprising the 116-139th sequence region of the cytotoxic protein alpha-sarcin Biophys. J. 68 1995 2387 2395
39. G. Fujii, M.E. Selsted, and D. Eisenberg Defensins promote fusion and lysis of negatively charged membranes Protein Sci. 2 1993 1301 1312
40. C.P. Hill, J. Yee, M.E. Selsted, and D. Eisenberg Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization Science 251 1991 1481 1485
41. A.T. Petkova, Y. Ishii, J.J. Balbach, O.N. Antzutkin, R.D. Leapman, F. Delaglio, and R. Tycko A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. USA 99 2002 16742 16747